Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | Ms. Sumi ShrishrimalExec. VP & Chief Risk Officer | -1,72k | 185,65k | Verkauf | 108,19 | 40,29k | -4,09% |
| 2026-05-11 | Mr. Abhijit Y. TalwalkarIndependent Chairman | 5,31k | 56,89k | Automatic Acquisition | 10,71 | 18,94k | 38,98% |
| 2026-05-11 | Mr. Abhijit Y. TalwalkarIndependent Chairman | -5,31k | 569,54k | Derivative Exercise and Sale | 10,71 - 120,53 | 18,94k | - |
| 2026-05-04 | Mr. Brian LawrenceExec. VP & CTO | -1,01k | 122,49k | Verkauf | 120,80 | 20,15k | -4,79% |
| 2026-03-16 | Mr. Mervin SmithExec. VP of Business Operations | -2,59k | 295,47k | Automatic Disposition | 114,30 | 5,77k | -30,96% |
| 2026-03-02 | Dr. Minang P. TurakhiaChief Medical & Scientific Officer and Exec. VP of Advanced Technologies | -4,03k | 517,26k | Verkauf | 128,45 | 25,23k | -13,77% |
| 2026-03-02 | Ms. Sumi ShrishrimalExec. VP & Chief Risk Officer | -2,83k | 363,48k | Verkauf | 128,44 | 41,87k | -6,33% |
| 2026-03-02 | Mr. Mervin SmithExec. VP of Business Operations | -1,35k | 173,65k | Verkauf | 128,44 | 8,35k | -13,94% |
| 2026-03-02 | Mr. Chad M. PattersonChief Commercial and Product Officer | -4,44k | 570,80k | Verkauf | 128,44 | 24,90k | -15,14% |
| 2026-03-02 | Mr. Patrick Michael MurphyChief Business & Legal Officer | -4,36k | 559,62k | Verkauf | 128,44 - 128,45 | 63,20k | -6,45% |
| 2026-03-02 | Mr. Marc RosenbaumSenior VP of Finance & CAO | -816,00 | 104,81k | Verkauf | 128,45 | 7,50k | -9,81% |
| 2026-03-02 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -3,40k | 436,08k | Verkauf | 128,44 - 128,45 | 35,76k | -8,67% |
| 2026-03-02 | Mr. Quentin S. BlackfordPresident, CEO & Director | -13,81k | 1,77M | Verkauf | 128,44 | 120,70k | -10,27% |
| 2026-02-25 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -5,19k | 702,55k | Verkauf | 135,42 | 30,79k | -14,42% |
| 2026-02-25 | Dr. Minang P. TurakhiaChief Medical & Scientific Officer and Exec. VP of Advanced Technologies | -7,80k | 1,06M | Verkauf | 135,42 | 22,85k | -25,46% |
| 2026-02-25 | Mr. Mervin SmithExec. VP of Business Operations | -4,04k | 547,23k | Verkauf | 135,42 | 6,68k | -37,71% |
| 2026-02-25 | Ms. Sumi ShrishrimalExec. VP & Chief Risk Officer | -6,22k | 841,90k | Verkauf | 135,42 | 39,18k | -13,69% |
| 2026-02-25 | Mr. Marc RosenbaumSenior VP of Finance & CAO | -4,80k | 649,60k | Verkauf | 135,42 | 6,78k | -41,44% |
| 2026-02-25 | Mr. Chad M. PattersonChief Commercial and Product Officer | -8,97k | 1,21M | Verkauf | 135,42 | 20,96k | -29,96% |
| 2026-02-25 | Mr. Patrick Michael MurphyChief Business & Legal Officer | -7,81k | 1,06M | Verkauf | 135,42 | 60,54k | -11,42% |
| 2026-02-25 | Mr. Quentin S. BlackfordPresident, CEO & Director | -25,54k | 3,46M | Verkauf | 135,42 | 109,94k | -18,85% |
| 2026-02-24 | Mr. Marc RosenbaumSenior VP of Finance & CAO | -280,00 | 39,45k | Automatic Disposition | 140,91 | 2,37k | -10,58% |
| 2026-02-24 | Mr. Mervin SmithExec. VP of Business Operations | -732,00 | 103,15k | Automatic Disposition | 140,91 | 1,51k | -32,69% |
| 2026-02-23 | Mr. Abhijit Y. TalwalkarIndependent Chairman | -5,31k | 717,09k | Derivative Exercise and Sale | 10,71 - 147,62 | 18,94k | - |
| 2025-12-02 | Mr. Chad M. PattersonChief Commercial and Product Officer | -280,00 | 51,75k | Automatic Disposition | 184,83 | 12,61k | -2,17% |
| 2025-12-02 | Mr. Patrick Michael MurphyChief Business & Legal Officer | -2,48k | 458,01k | Verkauf | 184,83 | 53,28k | -4,44% |
| 2025-11-10 | Mr. Abhijit Y. TalwalkarIndependent Chairman | -5,31k | 868,07k | Derivative Exercise and Sale | 10,71 - 177,85 | 18,94k | - |
| 2025-11-03 | Mr. Quentin S. BlackfordPresident, CEO & Director | -14,06k | 2,57M | Verkauf | 182,94 | 88,79k | -13,67% |
| 2025-10-31 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -8,00k | 1,66M | Automatic Disposition | 207,44 | 26,57k | -23,14% |
| 2025-09-03 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -5,00k | 875,00k | Automatic Disposition | 175,00 | 34,57k | -12,64% |
| 2025-09-02 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -737,00 | 123,29k | Verkauf | 167,28 | 39,57k | -1,83% |
| 2025-08-22 | Ms. Sumi ShrishrimalExec. VP & Chief Risk Officer | -653,00 | 109,13k | Automatic Disposition | 167,12 | 34,03k | -1,88% |
| 2025-08-11 | Mr. Marc RosenbaumSenior VP of Finance & CAO | -226,00 | 35,92k | Automatic Disposition | 158,93 | 2,64k | -7,87% |
| 2025-08-11 | Mr. Abhijit Y. TalwalkarIndependent Chairman | -5,31k | 782,49k | Derivative Exercise and Sale | 10,71 - 158,68 | 18,94k | - |
| 2025-08-06 | Mr. Chad M. PattersonChief Commercial and Product Officer | -2,56k | 406,17k | Automatic Disposition | 158,97 | 12,89k | -16,54% |
| 2025-08-05 | Mr. Quentin S. BlackfordPresident, CEO & Director | -30,00k | 4,82M | Automatic Disposition | 158,85 - 165,00 | 102,85k | -22,58% |
| 2025-08-04 | Mr. Mervin SmithExec. VP of Business Operations | -616,00 | 101,25k | Verkauf | 164,36 | 2,24k | -21,58% |
| 2025-08-04 | Mr. Chad M. PattersonChief Commercial and Product Officer | -2,71k | 444,92k | Verkauf | 164,36 | 15,45k | -14,91% |
| 2025-07-02 | Dr. Minang P. TurakhiaChief Medical & Scientific Officer and Exec. VP of Advanced Technologies | -1,42k | 206,48k | Verkauf | 145,41 | 15,34k | -8,47% |
| 2025-06-23 | Mr. Daniel G. WilsonCFO & Principal Financial Officer | -3,00k | 450,00k | Automatic Disposition | 150,00 | 40,31k | -6,93% |
| 2025-06-23 | Mr. Chad M. PattersonChief Commercial and Product Officer | -936,00 | 140,40k | Automatic Disposition | 150,00 | 12,89k | -6,77% |
| 2025-06-10 | Mr. Chad M. PattersonChief Commercial and Product Officer | -363,00 | 54,45k | Automatic Disposition | 150,00 | 13,83k | -2,56% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
